Dr. Nagakrishnal Nachimuthu, MD

Dr. Nachimuthu practices at St. Luke's Health - The Woodlands Hospital in The Woodlands, Texas, part of CommonSpirit Health.

Dr. Nachimuthu's NPI, 1073892048, was assigned on August 9, 2011. Dr. Nachimuthu holds Texas license Q6451.

Dr. Nachimuthu's primary practice is St. Luke's Health - the Woodlands Hospital, at 17200 St Luke's Way, The Woodlands, TX 77384 in Montgomery County. The practice phone is (936) 266-4050.

Dr. Nachimuthu's primary practice is St. Luke's Health - The Woodlands Hospital in The Woodlands, Texas, part of CommonSpirit Health. Dr. Nachimuthu is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Baylor St. Luke’s Medical Group. Dmand AI also links Dr. Nachimuthu to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nachimuthu practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Nachimuthu's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Nachimuthu is board certified in infectious disease by the American Board of Internal Medicine. Dr. Nachimuthu is licensed in Texas.

CMS data shows 533 Medicare services from Dr. Nachimuthu across 6 procedure codes in 2024, for 178 Medicare patients. Medicare paid $46,691 for them.

CMS counts 178 Medicare patients who saw Dr. Nachimuthu in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nachimuthu's median patient age at 67, with 45% women.

In 2024, Dr. Nachimuthu wrote 526 Medicare Part D claims for 125 patients. 76% of them were for generic drugs. CMS names the drug for 330 of them, across 15 drugs with 11 or more claims each, at $310,208 in total drug cost. In 2023, CMS named 1,022 claims across 34 drugs.

Dr. Nachimuthu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nachimuthu as offering telehealth.

Dmand AI links 3 papers to Dr. Nachimuthu, published from 2020 to 2024. 2020 was the busiest year, with 2. Dr. Nachimuthu has published most often in Cureus. Dr. Nachimuthu's most frequent co-authors are Santosh Yatam Ganesh, MBBS, MD, Mayar Al Mohajer, MD and Ashok Balasubramanyam, MD.

CMS Open Payments shows 82 general payments to Dr. Nachimuthu from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Gilead Sciences, Inc. paid the most, $715.